Full Breakdown
Genetic Impact of Agent Orange Exposure on Bone Marrow Cancers
3/24/2026, 5:12:38 PM
Study Overview and Findings
A recent study published in *Blood Advances* has revealed significant genetic changes linking exposure to Agent Orange with myelodysplastic syndromes (MDS), a group of bone marrow cancers that can progress to acute leukemia. Conducted by Mikkael A. Sekeres, M.D., chief of hematology at Sylvester Comprehensive Cancer Center, the research builds on earlier findings presented at the 2025 American Society of Hematology (ASH) Annual Meeting. The study highlights that approximately 2.6 million U.S. service members were potentially exposed to Agent Orange, an herbicide used during the Vietnam War, which contained dioxin, a toxic chemical disrupting cellular processes.
The study analyzed data from the National Heart, Lung, and Blood Institute's MDS Natural History Study, involving 2,115 patients, of whom 130 reported Agent Orange exposure. Notably, 54% of exposed patients received a diagnosis of MDS or a related precursor condition, compared to 37% of unexposed patients. Furthermore, exposed veterans were diagnosed at a younger age and exhibited a higher likelihood of disease progression within the first two years post-diagnosis.
Genetic Changes and Implications
The research identified that veterans exposed to Agent Orange were more than twice as likely to exhibit high-risk chromosome abnormalities, which suggest a more aggressive disease course. Specific mutations, including TET2, SRSF2, U2AF1, ZRSR2, and KRAS, were found more frequently in this group, indicating a disruption in cellular processes critical for maintaining healthy bone marrow cells. Sekeres noted, “It’s not a single event that leads to this cancer. You acquire one mutation, then another,” emphasizing the cumulative effect of these genetic changes over decades.
Demographic Disparities
An additional finding revealed a disproportionate representation of Black men among those reporting Agent Orange exposure, with about one in five exposed male patients being Black—more than double the rate seen among unexposed men. This raises concerns about the potential vulnerability of certain groups during military service, warranting further investigation into exposure patterns and long-term health risks.
Official Statements & Responses
Sekeres expressed hope that this study will influence national review bodies, such as the Institute of Medicine, to recognize Agent Orange exposure as a risk factor for MDS. He stated, “We have aging veterans developing MDS who are being told by the Veterans Association that they can't get their health care covered... because there hasn't been an official association made.” The findings aim to provide the necessary data for veterans to access service-connected care.
Criticism & Opposition
While the study presents compelling data linking Agent Orange to MDS, it does not establish a definitive cause-and-effect relationship. Critics may argue that further research is needed to solidify these findings and address the complexities of environmental risk factors in cancer development.
Verbatim Quotes
- “It's not a single event that leads to this cancer. You acquire one mutation, then another. Over years or decades, those changes build,” — Mikkael A. Sekeres, M.D.
- “We're hoping that the Institute of Medicine will recognize that Agent Orange exposure is a risk factor for MDS,” — Mikkael A. Sekeres, M.D.
- “We have aging veterans developing MDS who are being told by the Veterans Association that they can't get their health care covered to the extent they need because there hasn't been an official association made,” — Mikkael A. Sekeres, M.D.
